• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群的乳腺癌患者队列中5年局部、区域和远处复发事件的预测因素。

Predictors of 5-year local, regional, and distant recurrent events in a population-based cohort of breast cancer patients.

作者信息

Fung Filgen, Cornacchi Sylvie D, Vanniyasingam Thuva, Dao Dyda, Thabane Lehana, Simunovic Marko, Hodgson Nicole, O'Brien Mary Ann, Reid Susan, Heller Barbara, Lovrics Peter J

机构信息

Department of Surgery, McMaster University, St. Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada.

Department of Clinical Epidemiology and Biostatistics, McMaster University and Biostatistics Unit, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.

出版信息

Am J Surg. 2017 Feb;213(2):418-425. doi: 10.1016/j.amjsurg.2016.03.016. Epub 2016 Jun 14.

DOI:10.1016/j.amjsurg.2016.03.016
PMID:27424042
Abstract

BACKGROUND

The study purpose was to identify tumor and surgeon predictors of local recurrence (LR), regional recurrence (RR), and distant metastasis (DM) after breast cancer (BC) surgery in a population-based cohort.

METHODS

Consecutive BC surgical cases from 12 hospitals in South Central Ontario between May 2006 and October 2006 were included. Data collected on chart review included patient and tumor factors, surgery type, adjuvant treatment, surgeon specialty, surgeon case volume, and practice type. Univariate and multivariable survival analyses were performed.

RESULTS

Median follow-up was 5.5 years for 402 patients (97% of sample). LR, RR, and DM occurred in 18 (4.5%), 10 (2.5%), and 47 (12%) patients, respectively. Significant predictors of BC recurrence (LR or RR or DM) were tumor size and grade, nodal status, and lymphovascular invasion on multivariable analysis.

CONCLUSION

Tumor factors such as size, grade, lymphovascular invasion, and nodal status predicted BC recurrence, while practice type, surgeon specialty, and case volume did not.

摘要

背景

本研究目的是在一个基于人群的队列中确定乳腺癌(BC)手术后局部复发(LR)、区域复发(RR)和远处转移(DM)的肿瘤及外科医生预测因素。

方法

纳入2006年5月至2006年10月间安大略省中南部12家医院连续的BC手术病例。通过病历审查收集的数据包括患者和肿瘤因素、手术类型、辅助治疗、外科医生专业、外科医生手术量及执业类型。进行单变量和多变量生存分析。

结果

402例患者(占样本的97%)的中位随访时间为5.5年。LR、RR和DM分别发生在18例(4.5%)、10例(2.5%)和47例(12%)患者中。多变量分析显示,BC复发(LR或RR或DM)的显著预测因素为肿瘤大小和分级、淋巴结状态及淋巴管浸润。

结论

肿瘤大小、分级、淋巴管浸润及淋巴结状态等肿瘤因素可预测BC复发,而执业类型、外科医生专业及手术量则不能。

相似文献

1
Predictors of 5-year local, regional, and distant recurrent events in a population-based cohort of breast cancer patients.基于人群的乳腺癌患者队列中5年局部、区域和远处复发事件的预测因素。
Am J Surg. 2017 Feb;213(2):418-425. doi: 10.1016/j.amjsurg.2016.03.016. Epub 2016 Jun 14.
2
Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?局部复发是否会影响接受保乳治疗的早期乳腺癌患者的远处转移率和生存率?
Cancer. 2003 Feb 15;97(4):910-9. doi: 10.1002/cncr.11143.
3
Local recurrence risk after previous salvage mastectomy.既往挽救性乳房切除术后的局部复发风险。
Eur J Surg Oncol. 2016 Jul;42(7):980-5. doi: 10.1016/j.ejso.2016.03.008. Epub 2016 Mar 26.
4
A population-based study of treatment patterns, 10-year recurrence and breast cancer-specific mortality in a cohort of elderly patients with breast cancer.一项基于人群的研究,探讨了老年乳腺癌患者队列的治疗模式、10 年复发率和乳腺癌特异性死亡率。
Am J Surg. 2021 Aug;222(2):361-367. doi: 10.1016/j.amjsurg.2020.12.029. Epub 2020 Dec 25.
5
[Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].[40岁及以下年轻女性乳腺癌乳房切除或保乳手术后的局部复发:15年结果]
Magy Onkol. 2005;49(3):203, 205-8. Epub 2005 Oct 25.
6
Breast cancer recurrence following radioguided seed localization and standard wire localization of nonpalpable invasive and in situ breast cancers: 5-Year follow-up from a randomized controlled trial.不可触及的浸润性和原位乳腺癌在放射性粒子定位和标准导丝定位后的乳腺癌复发情况:一项随机对照试验的5年随访
Am J Surg. 2017 Apr;213(4):798-804. doi: 10.1016/j.amjsurg.2016.06.016. Epub 2016 Oct 20.
7
Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group.采用组织间近距离放疗的加速部分乳腺照射作为同侧乳腺肿瘤复发的第二种保守治疗方法:GEC-ESTRO乳腺癌工作组多中心研究
Radiother Oncol. 2013 Aug;108(2):226-31. doi: 10.1016/j.radonc.2013.03.026. Epub 2013 May 3.
8
Pattern of relapse after breast conserving therapy, a study of 1519 early breast cancer patients treated in the Central Region of Denmark 2000-2009.保乳治疗后的复发模式:一项对2000 - 2009年在丹麦中部地区接受治疗的1519例早期乳腺癌患者的研究
Acta Oncol. 2016 Aug;55(8):964-9. doi: 10.3109/0284186X.2016.1167955. Epub 2016 May 6.
9
Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.在一家机构接受保乳治疗的乳腺癌患者中,管理技术的变化以及疾病复发模式随时间的变化情况。
Cancer. 2004 Aug 15;101(4):713-20. doi: 10.1002/cncr.20410.
10
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.Ⅰ期和Ⅱ期乳腺癌保乳治疗或乳房切除术后局部和远处复发危险因素的差异:两项大型欧洲随机试验的汇总结果
J Clin Oncol. 2001 Mar 15;19(6):1688-97. doi: 10.1200/JCO.2001.19.6.1688.

引用本文的文献

1
Prognostic significance of ER-to-PR difference in ER+/HER2- early breast cancer.ER+/HER2- 早期乳腺癌中 ER 到 PR 的差异的预后意义。
Sci Rep. 2024 Oct 18;14(1):24431. doi: 10.1038/s41598-024-74608-w.
2
Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis.从 CSCs 中揭示 miRNA 的潜力,作为乳腺癌诊断和预后的新兴临床工具。
Int J Mol Sci. 2023 Nov 6;24(21):16010. doi: 10.3390/ijms242116010.
3
[MiR-4443 promotes migration and invasion of breast cancer cells by inhibiting PEBP1 expression].
[微小RNA-4443通过抑制PEBP1表达促进乳腺癌细胞的迁移和侵袭]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Dec 30;40(12):1712-1719. doi: 10.12122/j.issn.1673-4254.2020.12.03.
4
The Evolving Role of Disulfiram in Radiobiology and the Treatment of Breast Cancer.双硫仑在放射生物学及乳腺癌治疗中不断演变的作用
Onco Targets Ther. 2020 Oct 14;13:10441-10446. doi: 10.2147/OTT.S271532. eCollection 2020.
5
Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathway.Twist 介导的 PAR1 诱导通过抑制 Hippo 通路促进乳腺癌的进展和转移。
Cell Death Dis. 2020 Jul 9;11(7):520. doi: 10.1038/s41419-020-2725-4.
6
The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different molecular subtypes of breast cancer.磁共振成像在预测不同分子亚型乳腺癌患者新辅助化疗后病理完全缓解中的诊断准确性。
Quant Imaging Med Surg. 2020 Jan;10(1):197-210. doi: 10.21037/qims.2019.11.16.
7
Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers.预测早期乳腺癌新辅助治疗的反应:肿瘤、血液和影像学相关生物标志物。
Cancer Manag Res. 2018 Oct 9;10:4333-4347. doi: 10.2147/CMAR.S174435. eCollection 2018.
8
Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression.用于分析组织内脂素与乳腺癌进展中临床病理因素之间相互作用的累积受试者工作特征曲线
Cancer Cell Int. 2018 Feb 9;18:19. doi: 10.1186/s12935-018-0517-z. eCollection 2018.
9
miR-200b inhibits proliferation and metastasis of breast cancer by targeting fucosyltransferase IV and α1,3-fucosylated glycans.微小RNA-200b通过靶向岩藻糖基转移酶IV和α1,3-岩藻糖基化聚糖抑制乳腺癌的增殖和转移。
Oncogenesis. 2017 Jul 10;6(7):e358. doi: 10.1038/oncsis.2017.58.